Off-label, Overlooked or Novel Cancer Approaches (ONCAs): Overview

These therapies and other approaches have been developed by scientifically trained investigators operating both inside and outside mainstream cancer organizations. They have these defining characteristics: 

  1. Off-label (re-purposed) drugs not in standard use for cancer
  2. Neglected cancer therapies developed in mainstream science
  3. Cancer therapies with special promise in clinical trials
  4. Approaches developed by qualified researchers outside the US
  5. Selected diagnostic techniques in these categories

Read more about ONCAs.

Some examples:

Browse or search the BCCT Therapy Summaries.

More Information

Enter your comments or questions below.

Comments (0)




Allowed tags: <b><i><br>Add a new comment: